Mycophenolate mofetil Completed Phase 4 Trials for Hepatitis C Viral Infection / Transplantation, Liver / End Stage Liver Diseases Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00163657Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection
NCT00118742Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant
NCT00195988Comparison of Immunosuppression Protocols After LTx in Children
NCT00374231Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients
NCT00538265Benefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver Transplantation
NCT00545402A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.
NCT00717314A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients.